ZNTL icon

Zentalis Pharmaceuticals
ZNTL

Overview Fund Activity

142 hedge funds and large institutions have $1.34B invested in Zentalis Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 43 increasing their positions, 38 reducing their positions, and 14 closing their positions.

Holders
142
Holders Change
+22
Holders Change %
+18.33%
% of All Funds
2.06%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
36
Increased
43
Reduced
38
Closed
14
Calls
$1.14M
Puts
$36K
Net Calls
+$1.11M
Net Calls Change
-$15.4M

Top Buyers

1
MB
1
MPM BioImpact
Massachusetts
$23.9M
2
T. Rowe Price Investment Management
2
T. Rowe Price Investment Management
Maryland
$52.3M
3
Verition Fund Management
3
Verition Fund Management
Connecticut
$18.2M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$55M
5
PBA
5
Paradigm Biocapital Advisors
New York
$14.9M

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$69.3M
2
State Street
2
State Street
Massachusetts
$59.7M
3
Bank of America
3
Bank of America
North Carolina
$7.5M
4
IHAM
4
Integral Health Asset Management
New York
$0
5
Ensign Peak Advisors
5
Ensign Peak Advisors
Utah
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
151
Simplex Trading
Illinois
– -$470K -31,078 Closed
HighTower Advisors
152
HighTower Advisors
Illinois
– -$453K -29,905 Closed
Group One Trading
153
Group One Trading
Illinois
– -$433K -28,608 Closed
SAM
154
Sectoral Asset Management
Quebec, Canada
– -$111K -7,355 Closed
AT
155
Arlington Trust
Alabama
– -$1.06K -70 Closed
3 4 5 6
7